Home/Filings/4/0001062993-22-017071
4//SEC Filing

Schimmel Lawrence 4

Accession 0001062993-22-017071

CIK 0001479681other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 2:26 PM ET

Size

10.7 KB

Accession

0001062993-22-017071

Insider Transaction Report

Form 4
Period: 2022-04-02
Schimmel Lawrence
DirectorChief Medical Officer
Transactions
  • Conversion

    Convertible Promissory Note

    2022-04-02$100000.00/sh30,375.35$3,037,535,0000 total
    Exercise: $1.55From: 2019-11-19Exp: 2022-07-31Common Stock (19,597 underlying)
  • Conversion

    Common Stock

    2022-04-02$1.55/sh+19,597$30,375253,645 total
  • Exercise of In-Money

    Common Stock

    2022-04-02$1.55/sh+9,799$15,188263,444 total
  • Exercise of In-Money

    Warrant

    2022-04-029,7990 total
    Exercise: $1.55From: 2019-11-19Exp: 2022-07-31Common Stock (9,799 underlying)
Footnotes (2)
  • [F1]Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
  • [F2]Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.

Issuer

Nutex Health, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001793716

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 2:26 PM ET
Size
10.7 KB